Results 181 to 190 of about 7,777,750 (304)

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Burden of disease of seven dietary risk factors in population groups with similar lifestyle patterns in Denmark. [PDF]

Eur J Nutr
Sengupta S, Thomsen ST, Davydova A, Redondo HG, Jakobsen LS, Pires SM.   +5 more
europepmc   +1 more source

Willingness to Pay for HIV Prevention Commodities Among Key Population Groups in Nigeria. [PDF]

Glob Health Sci Pract, 2022
Durosinmi-Etti O, Nwala EK, Oki F, Ikpeazu A, Godwin E, Umoh P, Shaibu A, Ogundipe A, Kalaiwo A.   +8 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Moving Beyond Self‐Reported Race in Our Understanding of Cardiovascular Medicine

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Nancy Luo
doaj   +1 more source

Eating disorders across population groups with different weight status in Belgium: evidence for an integrative preventative approach. [PDF]

BMC Public Health
Geerinck F, Drieskens S, Gisle L, Vandevijvere S, Charafeddine R.   +4 more
europepmc   +1 more source

Comparison of Risk Allele Frequencies of Psoriasis-Associated Single-Nucleotide Polymorphisms in Different Population Groups. [PDF]

Ann Dermatol, 2023
Lee D, Koo T, Park J, Shin HT.
europepmc   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Do individual placement and support (IPS) service users leave their jobs soon? A subgroup analysis of a long-term follow-up study and a comparison with other population groups' data. [PDF]

Psychiatry Clin Neurosci
Yamaguchi S, Kawaguchi T, Iwanaga M, Usui K, Igarashi M, Shiozawa T, Koike J, Sato S, Fujii C.   +8 more
europepmc   +1 more source

Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest. [PDF]

Vaccine, 2022
Moss P, Berenbaum F, Curigliano G, Grupper A, Berg T, Pather S.   +5 more
europepmc   +1 more source